Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 14.5
(1.68%)
CNY 14.5
(1.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 84.97 Million CNY | 11.68% |
| 2022 | 76.08 Million CNY | -14.53% |
| 2021 | 89.02 Million CNY | 66.5% |
| 2020 | 53.47 Million CNY | 9.58% |
| 2019 | 48.79 Million CNY | -2.06% |
| 2018 | 49.82 Million CNY | 15.01% |
| 2017 | 43.32 Million CNY | -53.7% |
| 2016 | 93.55 Million CNY | 264.1% |
| 2015 | 25.69 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 21.66 Million CNY | 8.29% |
| 2024 Q3 | 23.76 Million CNY | -40.6% |
| 2024 Q1 | 20 Million CNY | -22.62% |
| 2023 Q3 | 18.09 Million CNY | -13.19% |
| 2023 FY | 84.97 Million CNY | 11.68% |
| 2023 Q4 | 25.85 Million CNY | 42.9% |
| 2023 Q1 | 19.82 Million CNY | -23.3% |
| 2023 Q2 | 20.84 Million CNY | 5.12% |
| 2022 Q2 | 15.13 Million CNY | -17.61% |
| 2022 Q4 | 25.85 Million CNY | 54.5% |
| 2022 Q3 | 16.73 Million CNY | 10.56% |
| 2022 Q1 | 18.37 Million CNY | -19.96% |
| 2022 FY | 76.08 Million CNY | -14.53% |
| 2021 FY | 89.02 Million CNY | 66.5% |
| 2021 Q4 | 22.95 Million CNY | -4.49% |
| 2021 Q2 | 23.76 Million CNY | 30.03% |
| 2021 Q3 | 24.02 Million CNY | 1.1% |
| 2021 Q1 | 18.27 Million CNY | 3.11% |
| 2020 Q2 | 12.59 Million CNY | 57.33% |
| 2020 FY | 53.47 Million CNY | 9.58% |
| 2020 Q3 | 15.13 Million CNY | 20.15% |
| 2020 Q1 | 8 Million CNY | -51.5% |
| 2020 Q4 | 17.72 Million CNY | 17.12% |
| 2019 Q2 | 7.71 Million CNY | -18.88% |
| 2019 FY | 48.79 Million CNY | -2.06% |
| 2019 Q4 | 16.51 Million CNY | 9.68% |
| 2019 Q3 | 15.05 Million CNY | 95.1% |
| 2019 Q1 | 9.51 Million CNY | 0.0% |
| 2018 Q1 | 10.64 Million CNY | 0.0% |
| 2018 Q2 | 10.64 Million CNY | 0.0% |
| 2018 FY | 49.82 Million CNY | 15.01% |
| 2017 FY | 43.32 Million CNY | -53.7% |
| 2016 FY | 93.55 Million CNY | 264.1% |
| 2015 FY | 25.69 Million CNY | 0.0% |